The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study

The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study

Abstract Background The aim was to investigate whether the use of N-acetylcysteine and ascorbic acid reduce contrast-induced nephropathy incidence in critical care patients. Methods This was a one-center, two-arm, prospective, randomized, open-label, controlled trial in the Intensive Care Unit of th...

Full description

Bibliographic Details
Main Authors: Eleni Palli, Demosthenes Makris, John Papanikolaou, Grigorios Garoufalis, Irini Tsilioni, Paris Zygoulis, Epaminondas Zakynthinos
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Critical Care
Subjects:
Contrast induced nephropathy
Intensive care
N-acetylcysteine
Ascorbic acid
8-Isoprostane
cystatin-C
Online Access:http://link.springer.com/article/10.1186/s13054-017-1862-3

Internet

http://link.springer.com/article/10.1186/s13054-017-1862-3

Similar Items